Cart
Free US shipping over $10
Proud to be B-Corp

The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry Stephanie K. Ashenden (Senior Artificial Intelligence and Machine Learning Data Scientist, AstraZeneca)

The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry By Stephanie K. Ashenden (Senior Artificial Intelligence and Machine Learning Data Scientist, AstraZeneca)

The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry by Stephanie K. Ashenden (Senior Artificial Intelligence and Machine Learning Data Scientist, AstraZeneca)


$20.23
Condition - Good
Only 1 left

Faster Shipping

Get this product faster from our US warehouse

The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry Summary

The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry by Stephanie K. Ashenden (Senior Artificial Intelligence and Machine Learning Data Scientist, AstraZeneca)

The Era of Artificial Intelligence, Machine Learning and Data Science in the Pharmaceutical Industry examines the drug discovery process, assessing how new technologies have improved effectiveness. Artificial intelligence and machine learning are considered the future for a wide range of disciplines and industries, including the pharmaceutical industry. In an environment where producing a single approved drug costs millions and takes many years of rigorous testing prior to its approval, reducing costs and time is of high interest. This book follows the journey that a drug company takes when producing a therapeutic, from the very beginning to ultimately benefitting a patient's life. This comprehensive resource will be useful to those working in the pharmaceutical industry, but will also be of interest to anyone doing research in chemical biology, computational chemistry, medicinal chemistry and bioinformatics.

About Stephanie K. Ashenden (Senior Artificial Intelligence and Machine Learning Data Scientist, AstraZeneca)

Dr. Ashenden is Senior Artificial Intelligence and Machine Learning Data Scientist at AstraZeneca, working in the Discovery Sciences, IMed-Biotech Unit. She received her PhD in 2018 from the Department of Chemistry, Cambridge University. Dr. Ashenden has three publications, but in very high impact resources (Methods in Enzymology, Journal of Chemical Information and Modeling, and Journal of Medicinal Chemistry). Dr. Ashenden is a very early career researcher, but has an extensive research network, academic and industrial experience, and a drive to conduct and report high quality research. She will be working with more experienced researchers on the project to help guide and offer experience.

Table of Contents

1. Introduction Drug Discovery 2. Intro to ML 3. Data Types 4. Target ID and Val 5. Hit Discovery 6. Lead Optimisation 7. Evaluating Safety and Toxicity 8. Precision Medicine and Finding the 'right patient': Date-driven Identification of Disease Subtypes 9. Image Analysis in Drug Discovery 10. Clinical Trials, Real World Evidence and Digital Medicine 11. To and From the Patient

Additional information

CIN0128200456G
9780128200452
0128200456
The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry by Stephanie K. Ashenden (Senior Artificial Intelligence and Machine Learning Data Scientist, AstraZeneca)
Used - Good
Paperback
Elsevier Science Publishing Co Inc
2021-04-28
264
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a used book - there is no escaping the fact it has been read by someone else and it will show signs of wear and previous use. Overall we expect it to be in good condition, but if you are not entirely satisfied please get in touch with us

Customer Reviews - The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry